ABSTRACT Forty-two stable patients with claudication were assigned to two groups. Group I (n 22) was submitted to regular, standardized treadmill exercise for 2 months. During this time the maximal and pain-free walking distances increased significantly (more than 100% 
Patients. Forty-four consecutive patients suffering from clinically overt intermittent claudication due to angiographically confirmed occlusive peripheral arterial disease of the legs were assigned to two groups. Assignment was dictated by the availability of space in the exercise program and was thus determined by external factors, but not strictly randomized. The distribution of decisive patient data was the same in both groups (table 1) .
None of the patients reported pain at rest or showed signs of gangrene. Inclusion criteria were informed consent and a maximal walking distance (treadmill, see below) of less than 200 m.
Exclusion criteria were contraindications to physical exercise, changes in walking distance in excess of 15% within the last 2 months, previous participation in a similar training scheme, cigarette smoking, or receipt of hemorrheologically active medication during the trial and preceding 2 weeks. Necessary medications were given throughout the trial. Group I was submitted to regular exercise; group II remained untreated. Both groups were studied in parallel. Forty clinically healthy nonsmokers matched for age, sex, and body mass index were also tested for blood rheology and served as controls.
Treatment. Exercise was performed on a treadmill ergometer (Woodyard) at 3 km/hr against an angle of 13 degrees twice per day, five times per week. It was continued to the maximal point (maximal walking distance). The moment of onset of ischemic pain was recorded (pain-free walking distance). In addition patients were asked to walk twice per day up to the point where ischemic pain occurred, and to continue all the physical exercise that they usually performed.
Variables tested. At baseline and after 1 and 2 months, the patients in groups I and II were examined for blood rheology CIRCULATION 
Results
Cross-sectional comparisons. At baseline there were no differences between groups I and II. The cross-sectional comparison between patients and matched controls at baseline showed that blood and plasma viscosity, blood cell filterability, and red cell aggregation differed significantly, suggesting a hemorrheologic deficit in the patients with occlusive peripheral arterial disease (table 2). After 2 months of training the differences were markedly less and failed to reach the level of significance. After the trial period groups I and the untreated patients of group II. There were no significant changes in the variables tested. Maximal and pain-free walking distances were prolonged by 16% and 18%, respectively, after 2 months, a difference that failed to reach the level of significance. Figure 1 demonstrates the changes in plasma viscosity, blood cell filterability, and maximal walking distance in both patients groups.
Discussion
The present results confirm previous reports about hemorrheologic abnormalities in patients with occlusive peripheral arterial disease. 14-16 Furthermore, they demonstrate a marked normalization of blood rheology (and walking distance) in patients with claudication over a 2 month period of physical exercise. There were no changes in the untreated patients of group II during this time.
Similar exercise schemes have been shown to be clinically effective in patients with stage II occlusive peripheral arterial disease. This was thought to be due to changes of muscular enzymatic activity,20 ameliorated oxygen utilization,2' enhanced capillarization of the ischemic musculature,22 changes in hemoglobin oxygen affinity,23 or economization of walking.24 According to our findings, it seems possible that the fluidification of blood is another as yet unappreciated mechanism contributing to the prolongation of the walking distance by regular exercise. The viscosity changes during the exercise program may seem small (7% to 9%) on first examination, but plasma viscosity, for example, showed extremely little inter-and intraindividual variation in the absence of disease. 13' 25 A change of 11/2 SDs, as observed here, can well be meaningful in terms of alterations in microcirculatory blood flow. 1-3, 14 Another way to change the fluidity of blood and thereby increase the walking distance in patients with claudication is isovolemic hemodilution. 15 One study in these patients shows that the alteration of blood viscosity induced by this therapy increases calf blood flow by 51% at rest and by 170% during reactive hyperemia. 16 Hence, the pathophysiologic relevance of the rheologic changes lies in the fact that, under the circulatory conditions of occlusive peripheral arterial disease, even seemingly minor changes in the flow properties of blood may increase nutritive flow in the hypoxic vascular bed. 3 The fluidity of blood represents the viscous component of the total peripheral resistance3 and is an important determinant of perfusion in the hypoxic microcirculation.2' 3 5, 7, 11. 14 Therapeutic interven tions aimed at normalizing blood rheology have been effective in prolonging the walking distance of patients with claudication; such interventions include hemodilution'5' 16 26 and oral drug treatment.2' The present results show that regular physical exercise can be used to ameliorate the flow properties of blood in these patients. A similar effect has been demonstrated 1.34 I plasma viscosity (mPa s) in healthy volunteers,7 so that the rheologic changes seem to be one of the inherent biological effects of exercise, independent of whether blood rheology is normal or abnormal to start with. Through the amelioration of the flow properties of blood, the oxygen supply to the hypoxic musculature may be improved,5' 7 16 28 in much the same way that hemodilution enhances oxygenation.29 Since exercise is not only free of negative side effects but also enhances various other body functions,30it could have obvious advantages in therapy and represent an alternative for drug treatment.
The present findings do not allow extrapolations about the relative importance of the hemorrheologic and the above-mentioned effects of exercise. Clearly the hemorrheologic alterations are not the only mechanisms leading to the clinical improvement. It is possible that their importance is only minor and it is likely that the cause for clinical improvement is multifactorial. However, rheologic changes do occur and could contribute to the efficacy of exercise as treatment.
Further studies are necessary to show the real extent of this contribution.
Similarly, the mechanisms involved in this exerciseinduced fluidification of blood cannot be fully defined at present. It is known that regular training leads to an expansion of plasma volume in healthy individuals.3' If this phenomenon also occurs in patients with claudication, it could partly explain the drop in blood and plasma viscosity demonstrated in this study. The constancy of the hematocrit, however, makes this explanation less likely. Possibly plasma volume expands, while simultaneously the red cell mass increases due to an erythropoietic stimulus produced by physical activity, thus leaving the hematocrit unchanged. A after a marathon race. 36 The present findings encourage research into the rheologic changes in leukocytes induced by regular exercise.
Clinical trials such as this one have limitations. A double-blind study would clearly be preferable. With exercise this is, however, not feasible. Nevertheless, the findings in the control group suggest that the effects observed in group I were indeed due to the exercise scheme.
In conclusion, we have demonstrated that the impaired blood rheology of patients with claudication can be normalized by regular exercise and that walking ability improves in parallel. The hemorrheologic alterations might represent a mechanism contributing to the prolongation of the walking distance. To improve the prognosis for these patients,37 exercise programs should be more widely recommended.
